QLF4113 in Participants With Metastatic Prostate Cancer
NCT07636707
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
140
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
QLF4113 for injection
Sponsor
Qilu Pharmaceutical Co., Ltd.